Germany health insurance spending on hospital treatment
Germany health insurance spending on hospital treatment stood at 28,929.29 EUR million in Q1 2026, according to Deutsche Bundesbank. It is one of the indicators in the Government finances (quarterly) table (Value · Quarterly), with a complete series running from Q1 2000 to Q1 2026. The complete series with an interactive chart, free to download.
This indicator in the Government finances (quarterly) table
| Indicator | Q1-2026 | Q4-2025 | Q3-2025 | Q2-2025 | Q1-2025 | Q4-2024 | Q3-2024 | Q2-2024 | Q1-2024 | Q4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scheme, expenditure, total | 93,201.03 | 90,638.41 | 88,016.97 | 87,514.58 | 86,490.03 | 84,126.56 | 81,579.28 | 82,224.16 | 80,253.23 | 78,859.89 | |
| Scheme, expenditure, hospital treatment | 28,929.29 | 28,145.22 | 27,062.85 | 26,568.94 | 26,490.97 | 25,998.28 | 24,561.95 | 24,187.14 | 24,188.27 | 23,363.97 | |
| Scheme, expenditure, administrative expenditure | 3,244.98 | 3,589.36 | 3,168.96 | 3,341.01 | 3,247.19 | 3,290.02 | 3,195.13 | 3,190.43 | 3,069.46 | 3,452.12 |
Understanding germany health insurance spending on hospital treatment
Capital channeled toward inpatient facilities tracks the heaviest single expenditure pillar within the statutory medical framework, mapping reimbursements for overnight patient stays, complex surgical procedures, and acute emergency admissions. Entirely distinct from the outpatient network or targeted dental interventions, this specific category measures the direct financial burden of operating the intensive care and general ward network. It encompasses the standardized diagnostic case fees paid to clinics, covering physician interventions, continuous bedside nursing care, and all pharmaceuticals administered during an individual's formal admission. However, the scope strictly isolates the operational treatment costs while filtering out the structural infrastructure investments that are traditionally financed through separate regional state budgets.
Evaluating inpatient financial flows demands careful handling of administrative billing cycles, as clinical institutions frequently submit clustered batch invoices rather than maintaining a steady, day-to-day stream of claims. Because specific respiratory seasons or localized epidemiological waves cause severe short-term bed occupancy fluctuations, analysts must rely on year-on-year metrics to uncover the underlying structural trends in surgical frequency and advanced medical technology pricing. Initial quarterly data releases routinely face subsequent corrections as disputed case-fee codings between hospital administrators and independent medical review boards are gradually resolved. Observers mapping the healthcare sector must remember that these figures track only the variable costs of treating insured individuals, completely ignoring the fixed capital expenditure required to construct, expand, or renovate the hospital facilities themselves.
Frequently asked questions
- Are the costs of building new hospital wings included in this data?
- No, the series isolates the operational treatment of patients, while facility construction is funded through separate regional government budgets.
- Does this cover medications given to patients while they are admitted?
- Yes, all pharmaceuticals administered during an inpatient stay are bundled into the standardized case fees captured here.
- Are outpatient surgeries performed at hospitals counted in this row?
- Specialized outpatient procedures conducted at clinical facilities are generally billed differently and fall outside this strictly inpatient metric.